[MAYBANK] YoY Quarter Result on 31-Dec-2022 [#4]

Announcement Date
27-Feb-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Dec-2022 [#4]
Profit Trend
QoQ- 0.08%
YoY- 5.37%
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 17,131,366 14,509,852 11,257,512 12,244,826 12,981,041 12,233,912 11,785,637 6.42%
PBT 2,949,598 3,307,125 2,720,193 1,992,130 3,263,604 3,095,595 2,926,148 0.13%
Tax -471,342 -1,099,189 -597,596 -351,190 -695,740 -644,795 -675,064 -5.80%
NP 2,478,256 2,207,936 2,122,597 1,640,940 2,567,864 2,450,800 2,251,084 1.61%
-
NP to SH 2,387,757 2,167,307 2,056,871 1,537,405 2,449,130 2,326,355 2,132,099 1.90%
-
Tax Rate 15.98% 33.24% 21.97% 17.63% 21.32% 20.83% 23.07% -
Total Cost 14,653,110 12,301,916 9,134,915 10,603,886 10,413,177 9,783,112 9,534,553 7.42%
-
Net Worth 94,641,502 85,956,773 85,785,748 84,436,116 81,570,693 75,330,108 72,420,516 4.55%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 3,738,673 3,616,238 3,562,481 4,327,924 4,384,131 3,535,898 3,423,632 1.47%
Div Payout % 156.58% 166.85% 173.20% 281.51% 179.01% 151.99% 160.58% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 94,641,502 85,956,773 85,785,748 84,436,116 81,570,693 75,330,108 72,420,516 4.55%
NOSH 12,060,236 12,054,127 11,878,513 11,241,361 11,241,361 11,049,682 10,782,745 1.88%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 14.47% 15.22% 18.85% 13.40% 19.78% 20.03% 19.10% -
ROE 2.52% 2.52% 2.40% 1.82% 3.00% 3.09% 2.94% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 142.05 120.37 94.80 108.93 115.48 110.72 110.16 4.32%
EPS 19.80 17.98 17.32 13.68 21.79 21.05 19.93 -0.10%
DPS 31.00 30.00 30.00 38.50 39.00 32.00 32.00 -0.52%
NAPS 7.8474 7.1309 7.2241 7.5112 7.2563 6.8174 6.769 2.49%
Adjusted Per Share Value based on latest NOSH - 12,054,127
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 141.97 120.24 93.29 101.47 107.58 101.38 97.67 6.42%
EPS 19.79 17.96 17.05 12.74 20.30 19.28 17.67 1.90%
DPS 30.98 29.97 29.52 35.87 36.33 29.30 28.37 1.47%
NAPS 7.843 7.1233 7.1091 6.9973 6.7598 6.2427 6.0016 4.55%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 8.89 8.70 8.30 8.46 8.64 9.50 9.80 -
P/RPS 6.26 7.23 8.76 7.77 7.48 8.58 8.90 -5.69%
P/EPS 44.90 48.39 47.92 61.86 39.66 45.12 49.18 -1.50%
EY 2.23 2.07 2.09 1.62 2.52 2.22 2.03 1.57%
DY 3.49 3.45 3.61 4.55 4.51 3.37 3.27 1.09%
P/NAPS 1.13 1.22 1.15 1.13 1.19 1.39 1.45 -4.06%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 28/02/24 27/02/23 24/02/22 25/02/21 27/02/20 26/02/19 28/02/18 -
Price 9.51 8.75 8.64 8.09 8.51 9.55 10.46 -
P/RPS 6.69 7.27 9.11 7.43 7.37 8.63 9.50 -5.67%
P/EPS 48.03 48.67 49.88 59.15 39.06 45.36 52.49 -1.46%
EY 2.08 2.05 2.00 1.69 2.56 2.20 1.91 1.43%
DY 3.26 3.43 3.47 4.76 4.58 3.35 3.06 1.06%
P/NAPS 1.21 1.23 1.20 1.08 1.17 1.40 1.55 -4.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment